VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,380,000 | -23.4% | 68,500 | 0.0% | 0.36% | -8.4% |
| Q1 2016 | $1,802,000 | -47.5% | 68,500 | +103.0% | 0.39% | -22.1% |
| Q4 2015 | $3,431,000 | +22.1% | 33,750 | +114.3% | 0.50% | +40.2% |
| Q3 2015 | $2,809,000 | -72.4% | 15,750 | -65.6% | 0.36% | -64.0% |
| Q2 2015 | $10,163,000 | +11.8% | 45,750 | 0.0% | 1.00% | +5.2% |
| Q1 2015 | $9,087,000 | -35.6% | 45,750 | -53.6% | 0.95% | -60.6% |
| Q4 2014 | $14,103,000 | +9.1% | 98,550 | 0.0% | 2.40% | +50.5% |
| Q3 2014 | $12,930,000 | – | 98,550 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |